Clostridium perfringens Type A in Broilers: Necrotic Enteritis Diagnosis and Alternatives to Antibiotics

Introduction

Necrotic enteritis (NE) is an economically significant enteric disease of broiler chickens caused by Clostridium perfringens type A and, less frequently, type C. The disease manifests in acute clinical forms with high mortality and subclinical forms that impair feed conversion and weight gain [1, 2]. C. perfringens is a Gram-positive, spore-forming, anaerobic rod that is ubiquitous in poultry litter and the intestinal tract of healthy birds [3]. The transition from commensal carrier state to pathogen is driven by a confluence of predisposing factors that disrupt the intestinal ecosystem and allow bacterial overgrowth and toxin production [4].

The primary virulence factor in type A strains is NetB toxin, a pore-forming toxin essential for the development of NE lesions [5]. Other toxins, including alpha-toxin (phospholipase C) and TpeL, contribute to pathogenesis but are not sufficient alone to cause disease [6]. The emergence of antibiotic resistance and consumer demand for antibiotic-free poultry production have accelerated research into alternatives such as probiotics, feed enzymes, and vaccination strategies [7, 8].

This article provides a comprehensive review of the pathogenesis, diagnostic approaches, and non-antibiotic control strategies for C. perfringens type A-associated NE in broiler chickens.

Predisposing Factors

The development of NE is multifactorial. Predisposing factors create an intestinal environment permissive for C. perfringens proliferation and toxin production.

Dietary Factors

High-protein diets, particularly those rich in animal-derived proteins (fishmeal, meat and bone meal), provide substrates for C. perfringens growth [9]. Viscous grains such as wheat, barley, and rye increase digesta viscosity, slowing transit time and promoting bacterial fermentation [10]. Non-starch polysaccharides (NSPs) in these grains are poorly digested by poultry and serve as fermentable substrates for clostridial proliferation [11].

Coccidiosis

Coccidiosis caused by Eimeria species, particularly Eimeria maxima and Eimeria acervulina, is the most important infectious predisposing factor [12]. Coccidial infection damages the intestinal epithelium, providing serum proteins and nutrients that favor C. perfringens growth. The inflammatory response also alters the gut microenvironment, reducing oxygen tension and creating favorable conditions for anaerobic bacteria [13]. The interaction between coccidiosis and NE is well documented in experimental models where subclinical coccidial infection consistently precipitates clinical NE [14].

Immunosuppression

Immunosuppressive agents, including Infectious Bursal Disease Virus variants and Chicken Astrovirus, compromise the intestinal immune barrier and increase susceptibility to NE [15]. Stress from high stocking density, poor ventilation, and heat stress also impairs mucosal immunity [16].

Antimicrobial Use

Subtherapeutic levels of certain antibiotics (e.g., ionophore anticoccidials) can suppress C. perfringens populations. However, withdrawal of antibiotic growth promoters has been associated with increased NE incidence in many regions [17].

Gross and Microscopic Lesions

Gross Pathology

Acute NE typically presents in broilers aged 2 to 6 weeks. Gross lesions are confined to the small intestine, particularly the jejunum and ileum. The intestinal wall is distended, friable, and covered with a pseudomembrane composed of fibrin, necrotic debris, and bacterial cells [18]. The mucosal surface appears rough, with a characteristic "Turkish towel" appearance. Luminal contents are often dark, watery, and foul-smelling. In severe cases, the intestinal wall may perforate, leading to peritonitis [19].

Subclinical NE presents with milder lesions: focal mucosal thickening, small ulcers, and catarrhal enteritis. These lesions are often missed during routine necropsy but contribute significantly to production losses [20].

Microscopic Pathology

Histological examination reveals coagulative necrosis of the villi, with extensive fibrin deposition and infiltration of heterophils and macrophages [21]. The lamina propria is congested and edematous. Large Gram-positive rods are visible in the necrotic debris and adherent to the mucosal surface. In chronic cases, there is villous atrophy and crypt hyperplasia, indicating ongoing repair [22].

Pathogenesis and Virulence Factors

NetB Toxin

NetB is a 33 kDa beta-pore-forming toxin belonging to the alpha-hemolysin family [5]. NetB oligomerizes on the surface of host cells, forming transmembrane pores that disrupt ion gradients and cause osmotic lysis. NetB is required for NE pathogenesis; isogenic netB knockout mutants fail to cause disease in experimental models [23].

Alpha-Toxin

Alpha-toxin (CPA) is a phospholipase C that hydrolyzes phosphatidylcholine and sphingomyelin, disrupting cell membranes and activating the arachidonic acid cascade [24]. While historically considered the primary virulence factor, studies show that CPA is not essential for NE. Strains lacking CPA can still cause disease if they carry NetB [25].

TpeL

TpeL is a large clostridial toxin with glycosyltransferase activity that modifies small GTPases, disrupting the actin cytoskeleton and inducing apoptosis [26]. TpeL is present in a subset of NE strains and may enhance virulence [27].

Other Factors

Additional virulence-associated factors include collagen adhesin (CnaA), sialidase (NanI), and a hyaluronidase that degrades extracellular matrix components [28, 29]. These factors facilitate bacterial colonization and tissue invasion.

Diagnosis

Clinical Diagnosis

Clinical signs of acute NE include depression, ruffled feathers, diarrhea, and sudden mortality. Mortality rates range from 2% to 50% in untreated flocks [30]. Subclinical NE is characterized by reduced weight gain, increased feed conversion ratio, and uneven flock uniformity [31].

Gross and Histopathological Examination

Necropsy with gross lesion scoring is the primary diagnostic method. Lesion scoring systems (0 to 4) based on the extent of intestinal necrosis and pseudomembrane formation are widely used [32]. Histopathology confirms the diagnosis and differentiates NE from other enteric diseases such as coccidiosis and Avian Pathogenic Escherichia coli (APEC) infections.

Microbiological Culture

C. perfringens can be cultured from intestinal contents or liver samples on selective media (e.g., tryptose-sulfite-cycloserine agar) under anaerobic conditions [33]. Quantitative culture is useful; counts exceeding 10^7 colony-forming units per gram of intestinal content are suggestive of NE [34].

PCR-Based Typing

Molecular typing is essential for confirming C. perfringens type A and detecting toxin genes. Multiplex PCR assays targeting the genes encoding alpha-toxin (cpa), NetB (netB), beta-toxin (cpb), epsilon-toxin (etx), iota-toxin (iap), and TpeL (tpeL) are standard [35].

Table 1. Multiplex PCR Targets for C. perfringens Typing

Real-time quantitative PCR (qPCR) can quantify C. perfringens load and netB gene copy number in intestinal samples [36]. Whole genome sequencing (WGS) provides high-resolution typing and detection of antimicrobial resistance genes [37].

Serological and Immunological Methods

Enzyme-linked immunosorbent assays (ELISAs) for detecting NetB antibodies in serum are used for seroprevalence studies and vaccine efficacy assessment [38]. Immunohistochemistry can localize NetB toxin in tissue sections [39].

Differential Diagnosis

NE must be differentiated from other causes of enteritis in broilers, including coccidiosis, Salmonella enterica Serovar Typhimurium infection, and Avian Coccidiosis. Concurrent infections are common, particularly with Eimeria species [40].

Alternatives to Antibiotics

Probiotics

Probiotics are live microorganisms that confer health benefits to the host. In NE control, probiotics compete with C. perfringens for nutrients and adhesion sites, produce antimicrobial compounds, and modulate the immune response [41].

Lactobacillus species, including Lactobacillus johnsonii and Lactobacillus reuteri, reduce C. perfringens counts and NE lesion scores in experimental models [42]. Bacillus species (e.g., Bacillus subtilis, Bacillus licheniformis) produce spores that survive feed processing and germinate in the intestine, producing bacteriocins and enzymes that degrade C. perfringens toxins [43]. Enterococcus faecium and Pediococcus acidilactici also show protective effects [44].

The efficacy of probiotics depends on strain selection, dose, and administration route. Multi-strain probiotics often outperform single strains [45].

Prebiotics

Prebiotics are non-digestible feed ingredients that selectively stimulate beneficial gut bacteria. Mannan-oligosaccharides (MOS) and fructo-oligosaccharides (FOS) bind to C. perfringens fimbriae, preventing adhesion to intestinal epithelial cells [46]. MOS also modulate the immune response by activating macrophages and increasing secretory IgA production [47].

Feed Enzymes

Exogenous enzymes reduce the negative effects of NSPs in cereal-based diets. Xylanases and beta-glucanases hydrolyze viscous NSPs, reducing digesta viscosity and limiting substrate availability for C. perfringens [48]. Proteases improve protein digestibility, reducing the amount of undigested protein reaching the lower intestine [49].

Table 2. Feed Enzymes and Their Mechanisms in NE Control

Organic Acids

Short-chain fatty acids (SCFAs) such as butyric acid, propionic acid, and formic acid lower intestinal pH and inhibit C. perfringens growth [50]. Butyrate also serves as an energy source for colonocytes, promoting intestinal barrier integrity [51]. Medium-chain fatty acids (MCFAs) such as caprylic and capric acid disrupt bacterial cell membranes [52].

Bacteriophages

Bacteriophages specific to C. perfringens have been isolated and characterized. Phage therapy reduces C. perfringens counts in vitro and in vivo [53]. Challenges include phage stability in feed, narrow host range, and the potential for bacterial resistance [54].

Antimicrobial Peptides

Host-derived antimicrobial peptides (AMPs) such as defensins and cathelicidins are part of the innate immune response. Synthetic AMPs and bacteriocins (e.g., nisin, pediocin) have activity against C. perfringens [55]. Nisin, produced by Lactococcus lactis, is approved as a feed additive in some regions [56].

Vaccines

Vaccination is a promising long-term strategy for NE control. Both live and inactivated vaccines have been developed.

Toxoid Vaccines: Formalin-inactivated NetB toxoid vaccines administered to breeder hens induce maternal antibodies that protect progeny during the first weeks of life [57]. Passive immunity reduces NE lesion scores and mortality in challenged chicks [58].

Recombinant Vaccines: Recombinant NetB protein expressed in E. coli or Bacillus systems elicits protective immune responses [59]. Multi-component vaccines combining NetB with alpha-toxoid or other antigens (e.g., CnaA) provide broader protection [60].

Live Vaccines: Attenuated C. perfringens strains and vectored vaccines using Salmonella or Lactococcus as delivery vehicles are under investigation [61].

Phytogenics

Plant-derived compounds with antimicrobial and anti-inflammatory properties include essential oils (thymol, carvacrol, cinnamaldehyde), saponins, and tannins [62]. Thymol and carvacrol disrupt C. perfringens cell membranes and reduce toxin production [63]. Saponins from Quillaja saponaria and Yucca schidigera have anti-protozoal activity against Eimeria, indirectly reducing NE risk [64].

Competitive Exclusion Products

Competitive exclusion products are undefined mixtures of intestinal bacteria derived from healthy adult chickens. These products are administered to day-old chicks to establish a protective gut microbiota [65]. While effective against Salmonella, their efficacy against C. perfringens is variable [66].

Integrated Control Strategies

No single alternative to antibiotics provides complete protection against NE. An integrated approach combining multiple strategies is recommended.

Figure 1. Integrated NE Control Decision Tree

graph TD
    A[Broiler Flock Risk Assessment], > B{High Risk?}
    B, >|Yes| C[Implement Multi-Strategy Program]
    B, >|No| D[Standard Management]
    C, > E[Feed Management]
    C, > F[Probiotics/Prebiotics]
    C, > G[Enzymes]
    C, > H[Vaccination]
    E, > I[Low NSP Diet]
    E, > J[Enzyme Supplementation]
    F, > K[Bacillus or Lactobacillus Strains]
    G, > L[Xylanase + Protease]
    H, > M[Maternal Immunization]
    I & J & K & L & M, > N[Monitor Lesion Scores & Performance]
    N, > O{NE Outbreak?}
    O, >|Yes| P[Review Program & Adjust]
    O, >|No| Q[Continue Surveillance]
    P, > C

Key components of an integrated program include:

1. Nutritional Management: Formulate diets with low NSP content, use highly digestible protein sources, and supplement with appropriate enzymes [67].
2. Coccidiosis Control: Implement vaccination or rotational anticoccidial programs to minimize Eimeria challenge [68].
3. Probiotic and Prebiotic Supplementation: Use multi-strain probiotics and MOS or FOS from day one [69].
4. Vaccination: Vaccinate breeder flocks with NetB toxoid to provide maternal antibody protection [70].
5. Biosecurity: Maintain strict hygiene, reduce stocking density, and minimize stress [71].

Conclusion

Clostridium perfringens type A remains a major cause of necrotic enteritis in broiler chickens, driven by NetB toxin and potentiated by dietary factors, coccidiosis, and immunosuppression. Accurate diagnosis requires a combination of gross pathology, histopathology, and PCR-based toxin gene typing. The global trend toward antibiotic-free production has accelerated the development of alternatives including probiotics, feed enzymes, organic acids, bacteriophages, and vaccines. An integrated, multi-factorial approach tailored to individual flock risk profiles offers the most effective strategy for NE control. Continued research into the mechanisms of C. perfringens pathogenesis and host-microbiota interactions will further refine these interventions.

References

[1] Van Immerseel F, De Buck J, Pasmans F, et al. Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathol. 2004;33(6):537-549.

[2] Timbermont L, Haesebrouck F, Ducatelle R, Van Immerseel F. Necrotic enteritis in broilers: an updated review on the pathogenesis. Avian Pathol. 2011;40(4):341-347.

[3] Craven SE, Stern NJ, Cox NA, Bailey JS, Berrang M. Cecal carriage of Clostridium perfringens in broiler chickens given mucosal starter culture. Avian Dis. 1999;43(3):484-490.

[4] McDevitt RM, Brooker JD, Acamovic T, Sparks NHC. Necrotic enteritis; a continuing challenge for the poultry industry. Worlds Poult Sci J. 2006;62(2):221-247.

[5] Keyburn AL, Boyce JD, Vaz P, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 2008;4(2):e26.

[6] Keyburn AL, Sheedy SA, Ford ME, et al. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun. 2006;74(11):6496-6500.

[7] Gaucher ML, Quessy S, Letellier A, et al. Impact of a drug-free program on broiler chicken production performances and on the prevalence of Clostridium perfringens. Poult Sci. 2015;94(8):1791-1801.

[8] Caly DL, D'Inca R, Auclair E, Drider D. Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: a microbiologist's perspective. Front Microbiol. 2015;6:1336.

[9] Drew MD, Syed NA, Goldade BG, et al. Effects of dietary protein source and level on intestinal populations of Clostridium perfringens in broiler chickens. Poult Sci. 2004;83(3):414-420.

[10] Annett CB, Viste JR, Chirino-Trejo M, et al. Necrotic enteritis: effect of barley, wheat and corn diets on proliferation of Clostridium perfringens type A. Avian Pathol. 2002;31(6):599-602.

[11] Kocher A, Choct M, Porter MD, Broz J. The effects of enzyme addition to broiler diets containing high concentrations of canola or sunflower meal. Poult Sci. 2000;79(12):1767-1774.

[12] Williams RB. Intercurrent coccidiosis and necrotic enteritis of chickens: rational, integrated disease management by maintenance of gut integrity. Avian Pathol. 2005;34(3):159-180.

[13] Collier CT, Hofacre CL, Payne AM, et al. Coccidia-induced mucogenesis promotes the onset of necrotic enteritis by supporting Clostridium perfringens growth. Vet Immunol Immunopathol. 2008;122(1-2):104-115.

[14] Shojadoost B, Vince AR, Prescott JF. The successful experimental induction of necrotic enteritis in chickens by Clostridium perfringens: a critical review. Avian Pathol. 2012;41(1):11-17.

[15] Rosenberger JK, Cloud SS. The effects of infectious bursal disease virus on the development of necrotic enteritis in broilers. Avian Dis. 1998;42(3):499-504.

[16] Tsiouris V, Georgopoulou I, Batzios C, et al. The role of an attenuated Eimeria vaccine in the control of necrotic enteritis in broiler chickens. Avian Dis. 2013;57(3):629-634.

[17] Van Immerseel F, Rood JI, Moore RJ, Titball RW. Rethinking our understanding of the pathogenesis of necrotic enteritis in chickens. Trends Microbiol. 2009;17(1):32-36.

[18] Long JR, Pettit JR, Barnum DA. Necrotic enteritis in broiler chickens. II. Pathology and proposed pathogenesis. Can J Comp Med. 1974;38(4):467-474.

[19] Helmboldt CF, Bryant ES. The pathology of necrotic enteritis in domestic fowl. Avian Dis. 1971;15(4):775-780.

[20] Kaldhusdal M, Hofshagen M. Barley inclusion and avoparcin supplementation in broiler diets. 2. Clinical, pathological, and bacteriological findings in a mild form of necrotic enteritis. Poult Sci. 1992;71(7):1145-1153.

[21] Olkowski AA, Wojnarowicz C, Chirino-Trejo M, Drew MD. Correlations of microscopic lesions and bacterial counts in the intestines of broiler chickens with necrotic enteritis. Avian Pathol. 2006;35(6):456-462.

[22] Gholamiandehkordi AR, Timbermont L, Lanckriet A, et al. Quantification of gut lesions in a subclinical necrotic enteritis model. Avian Pathol. 2007;36(5):375-382.

[23] Keyburn AL, Yan XX, Bannam TL, et al. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. Vet Res. 2010;41(2):21.

[24] Titball RW. Bacterial phospholipases C. Microbiol Rev. 1993;57(2):347-366.

[25] Keyburn AL, Bannam TL, Moore RJ, Rood JI. NetB, a pore-forming toxin from necrotic enteritis strains of Clostridium perfringens. Toxins. 2010;2(7):1913-1927.

[26] Coursodon CF, Glock RD, Moore KL, et al. TpeL-producing strains of Clostridium perfringens type A are highly virulent for broiler chicks. Anaerobe. 2012;18(1):117-121.

[27] Savva CG, Fernandes da Costa SP, Bokori-Brown M, et al. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J Biol Chem. 2013;288(5):3512-3522.

[28] Wade B, Keyburn AL, Seemann T, et al. The adherent abilities of Clostridium perfringens strains are critical for the pathogenesis of avian necrotic enteritis. Vet Microbiol. 2016;197:53-61.

[29] Li J, McClane BA. The sialidases of Clostridium perfringens type D strain CN3718 differ in their properties and sensitivities to inhibitors. Infect Immun. 2014;82(5):2010-2020.

[30] Lovland A, Kaldhusdal M. Severely impaired production performance in broiler flocks with high incidence of Clostridium perfringens-associated hepatitis. Avian Pathol. 2001;30(1):73-81.

[31] Kaldhusdal M, Schneitz C, Hofshagen M, Skjerve E. Reduced incidence of Clostridium perfringens-associated lesions and improved performance in broiler chickens treated with normal intestinal bacteria from adult fowl. Avian Dis. 2001;45(1):149-156.

[32] Prescott JF, Sivendra R, Barnum DA. The use of bacitracin in the prevention and treatment of experimentally-induced necrotic enteritis in the chicken. Can Vet J. 1978;19(7):181-183.

[33] Harmon SM, Kautter DA. Improved medium for enumeration of Clostridium perfringens. Appl Microbiol. 1978;35(4):688-692.

[34] Craven SE. Colonization of the intestinal tract by Clostridium perfringens and Campylobacter jejuni in broiler chickens. Poult Sci. 2000;79(3):339-345.

[35] Heikinheimo A, Korkeala H. Multiplex PCR assay for toxinotyping Clostridium perfringens isolates obtained from Finnish broiler chickens. Lett Appl Microbiol. 2005;40(6):407-411.

[36] Wise MG, Siragusa GR. Quantitative detection of Clostridium perfringens in the broiler fowl gastrointestinal tract by real-time PCR. Appl Environ Microbiol. 2005;71(7):3911-3916.

[37] Lacey JA, Johanesen PA, Lyras D, Moore RJ. Genomic diversity of necrotic enteritis-associated strains of Clostridium perfringens: a review. Avian Pathol. 2016;45(3):302-307.

[38] Lanckriet A, Timbermont L, De Gussem M, et al. The effect of commonly used anticoccidials and antibiotics in a subclinical necrotic enteritis model. Avian Pathol. 2010;39(1):63-68.

[39] Martin TG, Smyth JA. The ability of disease and non-disease producing strains of Clostridium perfringens from chickens to adhere to extracellular matrix molecules and Caco-2 cells. Anaerobe. 2010;16(3):239-244.

[40] Hofacre CL, Beacorn T, Collett S, Mathis G. Using competitive exclusion, mannan-oligosaccharide and other intestinal products to control necrotic enteritis. J Appl Poult Res. 2003;12(1):60-64.

[41] La Ragione RM, Woodward MJ. Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet Microbiol. 2003;94(3):245-256.

[42] Barbosa TM, Serra CR, La Ragione RM, et al. Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl Environ Microbiol. 2005;71(2):968-978.

[43] Teo AY, Tan HM. Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens. Appl Environ Microbiol. 2005;71(8):4185-4190